Clinical trial
Prospective Study on the Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients
NCT05156086 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study on the Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 16, 2021
- Completion date
- November 8, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 vaccination, renal transplant